HUNTINGTON NATIONAL BANK - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$24,000
+500.0%
190
+280.0%
0.00%
Q2 2019$4,000
-33.3%
500.0%0.00%
Q1 2019$6,000
+20.0%
500.0%0.00%
Q4 2018$5,000
-16.7%
500.0%0.00%
Q3 2018$6,000
+50.0%
500.0%0.00%
Q2 2018$4,000
+33.3%
500.0%0.00%
Q1 2018$3,0000.0%500.0%0.00%
Q4 2017$3,0000.0%500.0%0.00%
Q3 2017$3,000
-50.0%
500.0%0.00%
Q2 2017$6,0000.0%500.0%0.00%
Q1 2017$6,000
+20.0%
500.0%0.00%
Q4 2016$5,000
-37.5%
500.0%0.00%
Q3 2016$8,000
+14.3%
500.0%0.00%
Q2 2016$7,000
-50.0%
500.0%0.00%
Q1 2016$14,000
+100.0%
500.0%0.00%
Q4 2015$7,000
-12.5%
500.0%0.00%
Q3 2015$8,000
-33.3%
500.0%0.00%
Q2 2015$12,000
-14.3%
500.0%0.00%
Q1 2015$14,000
+75.0%
500.0%0.00%
Q4 2014$8,000500.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders